Study: Drinking coffee cuts risk of liver problems


Coffee drinkers, fill up that mug.
A new study published on Monday in the journal BMC Public Health found that drinking up to three or four cups of coffee — caffeinated or decaffeinated — a day cuts the risk of developing and dying from chronic liver diseases, CNN reports.
For the study, researchers followed 494,585 participants for nearly 12 years. They determined that coffee drinkers were 21 percent less likely to develop chronic liver disease, 20 percent less likely to develop chronic or fatty liver disease, and 49 percent less likely to die from chronic liver disease than those who do not drink coffee. The researchers found that the most benefit came from drinking ground (as opposed to instant) caffeinated or decaf coffee. Most coffee studies are based on 8-ounce cups of black coffee, CNN cautions.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Coffee is widely accessible, and the benefits we see from our study may mean it could offer a potential preventative treatment for chronic liver disease," study author Dr. Oliver Kennedy of Britain's University of Southampton said in a statement. "This would be especially valuable in countries with lower income and worse access to health care and where the burden of chronic liver disease is highest."
The American Liver Foundation says that over the last two decades, the number of people diagnosed with nonalcoholic fatty liver disease has more than doubled, and the American Cancer Society found that between 1980 and 2021, the rate of liver cancer more than tripled with death rates doubled.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
The best film reboots of all-time
The Week Recommends Creativity and imagination are often required to breathe fresh life into old material
-
'More must be done'
Instant Opinion Opinion, comment and editorials of the day
-
Are masked ICE agents America's new secret police?
Today's Big Question Critics say masks undermine trust in law enforcement
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia